Literature DB >> 7531681

Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.

S Nakamura1, M Seto, S Banno, S Suzuki, T Koshikawa, K Kitoh, Y Kagami, M Ogura, Y Yatabe, M Kojima.   

Abstract

Immunohistochemical expression of PRAD1/cyclin D1 protein has been investigated in 106 tissue specimens of 104 cases of lymphoma, non-neoplastic lymphoid disorders and other hematologic malignancies by employing the monoclonal antibody 5D4 with formalin-fixed paraffin-embedded sections, using the microwave oven heating method. Positive neoplastic cells were found in 60 (74%) of 81 cases of non-Hodgkin's lymphoma. The positivity pattern was nuclear in 17 (85%) of 20 cases of mantle cell lymphoma in which cytoplasmic staining was also seen. This pattern of cyclin D1 positivity was in contrast to the negative staining of normal reactive mantle zones. In the other cases, positivity appeared to lie within the cell cytoplasm without nuclear staining, and most of the nodal follicular and diffuse B-cell lymphomas variously expressed PRAD1/cyclin D1. In contrast, the reaction was absent in a significant number of T-cell and extranodal B-cell lymphomas. Immunolocalization of PRAD1/cyclin D1 expression appears to be a useful diagnostic adjunct to discriminate mantle cell lymphoma from other non-Hodgkin's lymphomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531681      PMCID: PMC5919397          DOI: 10.1111/j.1349-7006.1994.tb02940.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  31 in total

1.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

2.  Extranodal lymphoid infiltrates and mucosa-associated lymphoid tissue (MALT). A unifying concept.

Authors:  N L Harris
Journal:  Am J Surg Pathol       Date:  1991-09       Impact factor: 6.394

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.

Authors:  D D Weisenburger; H Kim; H Rappaport
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

5.  Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.

Authors:  L J Medeiros; J H Van Krieken; E S Jaffe; M Raffeld
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

6.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

7.  PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma.

Authors:  K Oka; T Ohno; K Kita; M Yamaguchi; N Takakura; K Nishii; H Miwa; S Shirakawa
Journal:  Br J Haematol       Date:  1994-04       Impact factor: 6.998

8.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

9.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.

Authors:  S E Bodrug; B J Warner; M L Bath; G J Lindeman; A W Harris; J M Adams
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

10.  Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.

Authors:  S Banno; K Yoshikawa; S Nakamura; K Yamamoto; T Seito; M Nitta; T Takahashi; R Ueda; M Seto
Journal:  Jpn J Cancer Res       Date:  1994-09
View more
  10 in total

1.  Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry.

Authors:  P Jain; G M Giustolisi; S Atkinson; M O Elnenaei; R Morilla; K Owusu-Ankomah; F Rafiq-Mohammed; E Matutes; A Wotherspoon; D Catovsky
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Primary hepatic marginal zone B-cell lymphoma with mantle cell lymphoma phenotype.

Authors:  G Ueda; K Oka; T Matsumoto; Y Yatabe; K Yamanaka; M Suyama; J Ariyama; S Futagawa; N Mori
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

Authors:  Y Imanishi; Y Hosokawa; K Yoshimoto; E Schipani; S Mallya; A Papanikolaou; O Kifor; T Tokura; M Sablosky; F Ledgard; G Gronowicz; T C Wang; E V Schmidt; C Hall; E M Brown; R Bronson; A Arnold
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 4.  Cyclin D1 and human neoplasia.

Authors:  R Donnellan; R Chetty
Journal:  Mol Pathol       Date:  1998-02

5.  Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.

Authors:  Michinori Ogura; Yasuo Morishima; Yukio Kobayashi; Naokuni Uike; Susumu Sugai; Takaaki Chou; Masaharu Kasai; Ikuo Miura; Tohru Murayama; Yoshihiro Matsuno; Shigeo Nakamura; Shigeo Mori; Yasuo Ohashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

6.  Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.

Authors:  D C Betticher; J Heighway; N Thatcher; P S Hasleton
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.

Authors:  M Kume; R Suzuki; Y Yatabe; Y Kagami; I Miura; A B Miura; Y Morishima; S Nakamura; M Seto
Journal:  Jpn J Cancer Res       Date:  1997-11

8.  Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.

Authors:  T Taniguchi; A Fujita; S Takahashi; K Uchimaru; M Yoshikawa; S Asano; T Fujita; T Motokura
Journal:  Jpn J Cancer Res       Date:  1998-02

9.  Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

Authors:  D C Betticher; J Heighway; P S Hasleton; H J Altermatt; W D Ryder; T Cerny; N Thatcher
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma.

Authors:  H Kuroda; H Komatsu; S Nakamura; Y Niitsu; T Takahashi; R Ueda; M Seto
Journal:  Jpn J Cancer Res       Date:  1995-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.